CPRD Feasibility Tool
Description: The requirement is for a white-labelled feasibility and population analytics platform, deployed within CPRD-managed Microsoft Azure infrastructure and operating exclusively against CPRD datasets formatted in the OMOP Common Data Model. The proposed solution must natively support the OMOP Common Data Model and should not require material restructuring, remodelling or transformation of CPRD OMOP datasets to operate. The platform must enable CPRD staff and CPRD-approved external client to conduct self-service feasibility studies and descriptive epidemiological analyses without requiring supplier intervention.
Summary: MHRA intends to procure a white-labelled feasibility and population analytics platform for the Clinical Practice Research Datalink (CPRD). The platform will be deployed within CPRD-managed Microsoft Azure infrastructure and used exclusively with CPRD datasets formatted in the OMOP Common Data Model. It must support the OMOP model natively, without requiring material restructuring, remodelling or transformation of CPRD data. CPRD staff and CPRD-approved external clients will use the platform for self-service feasibility studies and descriptive epidemiological analyses, without supplier intervention. This is an IT software package requirement, with delivery across the United Kingdom. The buyer is MHRA, the UK Medicines and Healthcare products Regulatory Agency, a central government public authority.